ORTHO-2C: Evaluation of a Conservative Treatment by Nocturnal Wrist Orthosis in the Non-surgical Management of Carpal Tunnel Syndrome (AMYLYONCARP)

Sponsor
Centre Hospitalier Saint Joseph Saint Luc de Lyon (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05483218
Collaborator
(none)
60
2
16

Study Details

Study Description

Brief Summary

This study focuses on the evaluation of 2 nocturnal wrist orthosis prescribed as part of a non-surgical management of carpal tunnel syndrome in order to determine their effectiveness in reducing the symptoms associated with the syndrome and to highlight the superiority or the inferiority of one over the other.

It will also be possible to assess their comfort and compliance as well as the impact of wearing them on neurological and muscular recovery (functional assessment).

Condition or Disease Intervention/Treatment Phase
  • Device: Nocturnal wrist orthosis wearing
N/A

Detailed Description

After selection of patients suffering from carpal tunnel syndrome during consultation visits, the study will be explained to them, an information sheet and a consent form will be given to them.

A subgroup of patients who have undergone a diagnostic electromyogram at the study center (defined as a functional assessment subgroup) will be randomized independently of the other participants (2 randomization lists will be generated).

The randomization will be done on 2 groups: one benefiting from a wrist orthosis called simple rest, and the other from a wrist-hand-finger orthosis called global rest.

An appointment for making the orthosis will be fixed with the manufacturer within one month of inclusion.

The follow-up will then be done by 2 telephone collection visits at 1 month then at 2 months of the implementation of the device then by a last visit at 3 months consisting in a consultation for the functional assessment subgroup and a phone call for the others.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Evaluation of a Conservative Treatment by Nocturnal Wrist Orthosis in the Non-surgical Management of Carpal Tunnel Syndrome
Anticipated Study Start Date :
Sep 1, 2022
Anticipated Primary Completion Date :
Sep 1, 2023
Anticipated Study Completion Date :
Jan 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: wrist orthosis

group benefiting from an orthosis that supports the wrist by covering the palm of the hand only

Device: Nocturnal wrist orthosis wearing
Nocturnal wearing of one of the 2 wrist orthosis kind

Experimental: wrist-hand-finger orthosis

group benefiting from an orthosis that supports the wrist by covering the palm of the hand and the fingers

Device: Nocturnal wrist orthosis wearing
Nocturnal wearing of one of the 2 wrist orthosis kind

Outcome Measures

Primary Outcome Measures

  1. Measure and compare the evolution over time of the effectiveness of the 2 nocturnal orthoses [Orthosis implementation, 1 month and 3 months after orthosis implementation]

    Score of Boston Carpal Tunnel Syndrome Questionnaire : SEVERITY SCALE OF SYMPTOMS (11 ITEMS): score from 1 to 5 (each item) + FUNCTIONAL EVALUATION SCALE (8 ITEMS): score from 1 to 5 (each item). Higher score means worse outcome.

Secondary Outcome Measures

  1. Evaluate the failure rate of treatment with nocturnal orthosis [3 months after orthosis implementation]

    Need for surgery / infiltration / initiation or increase of anti-inflammatory treatments

  2. Compare the patient's compliance with wearing the 2 types of nocturnal orthosis [1 month and 3 months after orthosis implementation]

    Score of "numerical scale of orthosis wearing duration" : from "never" to "every night". Higher score means better outcome.

  3. Compare the comfort of the 2 types of nocturnal orthosis [1 month and 3 months after orthosis implementation]

    Score of "numerical scale of comfort" : from "1" (very uncomfortable) to "5" (perfectly comfortable). Higher score means better outcome.

  4. Evaluate the impact of the precocity of the conservative treatment on its effectiveness [1 month and 3 months after orthosis implementation]

    Score of Boston Carpal Tunnel Syndrome Questionnaire : SEVERITY SCALE OF SYMPTOMS (11 ITEMS): score from 1 to 5 (each item) + FUNCTIONAL EVALUATION SCALE (8 ITEMS): score from 1 to 5 (each item). Higher score means worse outcome.

  5. Muscle strength recovery [Inclusion and 3 months after orthosis implementation]

    For the functional assessment sub-group : measure of muscle strength with a manual dynamometer

  6. Neurological recovery [Inclusion and 3 months after orthosis implementation]

    For the functional assessment sub-group : performing of an electromyogram

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients over 18 years of age with unilateral or bilateral, idiopathic or secondary carpal tunnel syndrome, without surgical indication (EMG with myelin sensory signs without axonal involvement)

  • signed consent

  • Affiliation to social security

Exclusion Criteria:
  • Patients with carpal tunnel syndrome with severity criteria

  • Patient refusal

  • Patient with disorders (psychological, behavioral) that may lead to poor compliance with the study treatment

  • Presence of skin lesion in the area of the orthosis

  • Current participation in another research protocol involving the human person

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Centre Hospitalier Saint Joseph Saint Luc de Lyon

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Saint Joseph Saint Luc de Lyon
ClinicalTrials.gov Identifier:
NCT05483218
Other Study ID Numbers:
  • ORTHO-2C
First Posted:
Aug 2, 2022
Last Update Posted:
Aug 2, 2022
Last Verified:
Aug 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 2, 2022